• LAST PRICE
    3.7500
  • TODAY'S CHANGE (%)
    Trending Up0.0300 (0.8065%)
  • Bid / Lots
    3.7500/ 10
  • Ask / Lots
    3.8000/ 1
  • Open / Previous Close
    3.7600 / 3.7200
  • Day Range
    Low 3.6800
    High 3.8900
  • 52 Week Range
    Low 3.4550
    High 14.5500
  • Volume
    6,543,961
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

  • Mar 22, 2024

      Show headlines and story abstract
    • 4:30PM ET on Friday Mar 22, 2024 by PR Newswire
      Companies Mentioned: PACB

      PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option (the "Option") covering an aggregate of 79,600 shares of PacBio common stock and restricted stock units ("RSUs") covering 39,800 shares of PacBio common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the "2020 Inducement Plan"), effective on March 18, 2024. The award was granted as an inducement material to such individual's entering into employment with PacBio in accordance with Nasdaq Marketplace Rule 5635(c)(4).

    • 4:30PM ET on Friday Mar 22, 2024 by Dow Jones
      Companies Mentioned: PACB

      PacBio Grants Equity Incentive Award to New Employee

      PR Newswire

      MENLO PARK, Calif., March 22, 2024

      MENLO PARK, Calif., March 22, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company's Board of Directors granted a non-qualified stock option (the "Option") covering an aggregate of 79,600 shares of PacBio common stock and restricted stock units ("RSUs") covering 39,800 shares of PacBio common stock to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the "2020 Inducement Plan"), effective on March 18, 2024. The award was granted as an inducement material to such individual's entering into employment with PacBio in accordance with Nasdaq Marketplace Rule 5635(c)(4).
  • Mar 12, 2024

Peers Headlines